What the FDA labels say about taking them together
Cannabidiol and stiripentol
Cannabidiol's FDA label of May 29, 2026 names stiripentol in its drug interactions section; the stiripentol label PlainMeds reads does not name cannabidiol. The cannabidiol label: “Stiripentol Concomitant use of EPIDIOLEX with stiripentol increases plasma exposures of stiripentol.”
Check it at the source: the cannabidiol FDA label on DailyMed (effective May 29, 2026, Jazz Pharmaceuticals, Inc.); the stiripentol FDA label on DailyMed (effective April 27, 2026, BIOCODEX, INC.).
What does the cannabidiol label say about stiripentol?
Cannabidiol label, drug interactionsStiripentol Concomitant use of EPIDIOLEX with stiripentol increases plasma exposures of stiripentol [see Clinical Pharmacology ( 12.3 )].
Source: FDA drug label (Epidiolex), Jazz Pharmaceuticals, Inc., effective May 29, 2026 (SPL set 8bf27097-4870-43fb-94f0-f3d0871d1eec), via openFDA; the full label on DailyMed
What does the stiripentol label say about cannabidiol?
Stiripentol's label (effective April 27, 2026) does not name cannabidiol in these sections. A label lists what its studies and reports found; it is not a complete list.
Source: FDA drug label (Diacomit), BIOCODEX, INC., effective April 27, 2026 (SPL set 58304ba8-9779-4658-811e-94ffe08c3f16), via openFDA; the full label on DailyMed
These are the labels' own sentences. PlainMeds does not grade interactions; a pharmacist or prescriber can say what they mean for one person's medicines.
Both medicines on the record
| Cannabidiol | Stiripentol | |
|---|---|---|
| Labeled for | n/a | n/a |
| Boxed warning | No | No |
| Pharmacy cost (NADAC) | n/a | n/a |
| Shortage now | No current entry | No current entry |
Source: FDA NDC Directory, CMS NADAC of October 7, 2026 and the FDA Drug Shortage Database (FDA files October 8, 2026)
What next?
- Check more medicines together
- up to five at once